BNP Paribas Financial Markets’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-2,571
| Closed | -$47.3K | – | 3494 |
|
|
2020
Q4 | $47.3K | Sell |
2,571
-478
| -16% | -$8.79K | ﹤0.01% | 2926 |
|
|
2020
Q3 | $55.9K | Buy |
3,049
+2,583
| +554% | +$47.4K | ﹤0.01% | 2804 |
|
|
2020
Q2 | $6.98K | Sell |
466
-3,292
| -88% | -$49.3K | ﹤0.01% | 3238 |
|
|
2020
Q1 | $59.5K | Buy |
3,758
+1,670
| +80% | +$26.4K | ﹤0.01% | 2851 |
|
|
2019
Q4 | $33.9K | Buy |
2,088
+162
| +8% | +$2.63K | ﹤0.01% | 3181 |
|
|
2019
Q3 | $28.6K | Buy |
1,926
+333
| +21% | +$4.95K | ﹤0.01% | 3140 |
|
|
2019
Q2 | $26.3K | Sell |
1,593
-863
| -35% | -$14.3K | ﹤0.01% | 3173 |
|
|
2019
Q1 | $42.5K | Buy |
2,456
+2,315
| +1,642% | +$40.1K | ﹤0.01% | 3006 |
|
|
2018
Q4 | $2.49K | Sell |
141
-238
| -63% | -$4.2K | ﹤0.01% | 3082 |
|
|
2018
Q3 | $6.88K | Sell |
379
-8
| -2% | -$145 | ﹤0.01% | 3246 |
|
|
2018
Q2 | $7.57K | Buy |
387
+380
| +5,429% | +$7.43K | ﹤0.01% | 3260 |
|
|
2018
Q1 | $123 | Hold |
7
| – | – | ﹤0.01% | 3555 |
|
|
2017
Q4 | $79 | Hold |
7
| – | – | ﹤0.01% | 3463 |
|
|
2017
Q3 | $75 | Hold |
7
| – | – | ﹤0.01% | 3493 |
|
|
2017
Q2 | $61 | Sell |
7
-58
| -89% | -$505 | ﹤0.01% | 3539 |
|
|
2017
Q1 | $767 | Sell |
65
-167
| -72% | -$1.97K | ﹤0.01% | 3170 |
|
|
2016
Q4 | $3.04K | Sell |
232
-672
| -74% | -$8.8K | ﹤0.01% | 3224 |
|
|
2016
Q3 | $13.1K | Buy |
904
+231
| +34% | +$3.35K | ﹤0.01% | 3096 |
|
|
2016
Q2 | $8.07K | Buy |
673
+593
| +741% | +$7.11K | ﹤0.01% | 3022 |
|
|
2016
Q1 | $1.49K | Sell |
80
-1,676
| -95% | -$31.3K | ﹤0.01% | 2461 |
|
|
2015
Q4 | $37.7K | Sell |
1,756
-735
| -30% | -$15.8K | ﹤0.01% | 2999 |
|
|
2015
Q3 | $42.2K | Buy |
2,491
+1,672
| +204% | +$28.3K | ﹤0.01% | 2989 |
|
|
2015
Q2 | $30.7K | Buy |
+819
| New | +$30.7K | ﹤0.01% | 2780 |
|